Evaluation of the metabolic capability of primary human hepatocytes in three‐dimensional cultures on microstructural plates
Authors:
- 13 March 2018
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 39 (4) , 187-195
Abstract
The NanoCulture Plate (NCP) is a novel microstructural plate designed as a base for the three‐dimensional culture of cells/tissues. This study examined whether or not the metabolic capability of human primary hepatocytes is well maintained during culture on NCPs. The hepatocytes formed aggregates after seeding and their ATP content was well maintained during culture for 21 days. Expression of CYP1A2, 2B6, 2C9, 2C19, 2D6, 2E1 and 3A4 mRNAs was detected throughout the 21‐day culture period. Addition of CYP substrate drugs (midazolam, diclofenac, lamotrigine and acetaminophen) resulted in the formation of multiple metabolites with a corresponding decrease in the amounts of the unchanged compounds. The inducers omeprazole, phenobarbital and rifampicin increased the levels of CYP1A2, 2B6 and 3A4 mRNAs by 110‐fold, 12.5‐fold and 5.4‐fold, respectively, at day 2, compared with control human hepatocytes. CYP activities were also increased at 2 days after inducer treatment (CYP1A2, 2.2‐fold; CYP2B6, 20.6‐fold; CYP3A4, 3.3‐fold). The results indicate that the hepatocyte spheroids on NCP have detectable and inducible metabolic abilities during the 7‐day culture period.Keywords
Funding Information
- Japan Agency for Medical Research and Development
This publication has 30 references indexed in Scilit:
- Preliminary Evaluation of Three-Dimensional Primary Human Hepatocyte Culture System for Assay of Drug-Metabolizing Enzyme-Inducing Potential2017
- Comparison of Liver Cell Models Using the Basel Phenotyping CocktailFrontiers in Pharmacology, 2016
- A Novel High-Throughput 3D Screening System for EMT Inhibitors: A Pilot Screening Discovered the EMT Inhibitory Activity of CDK2 Inhibitor SU9516PLOS ONE, 2016
- Nanoimprinting of Topographical and 3D Cell Culture ScaffoldsNanomedicine, 2014
- In Vitro Evaluation of Major In Vivo Drug Metabolic Pathways Using Primary Human Hepatocytes and HepaRG Cells in Suspension and a Dynamic Three-Dimensional Bioreactor SystemThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Assessment of Three Human in Vitro Systems in the Generation of Major Human Excretory and Circulating MetabolitesChemical Research in Toxicology, 2009
- Evolving concepts in liver tissue modeling and implications forin vitrotoxicologyExpert Opinion on Drug Metabolism & Toxicology, 2008
- Liquid Chromatography/Tandem Mass Spectrometry Detection of Covalent Binding of Acetaminophen to Human Serum AlbuminDrug Metabolism and Disposition, 2007
- Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- Lamotrigine, a new anticonvulsant: Pharmacokinetics in normal humansClinical Pharmacology & Therapeutics, 1987